FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

788026004: Antiprotozoal therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3778479015 Antiprotozoal therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3778480017 Antiprotozoal therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antiprotozoal therapeutic role Is a Antiparasitic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only pentamidine in pulmonary dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pentamidine isethionate 300 milligram/1 vial powder for conventional release solution for injection Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing pentamidine in pulmonary dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only nifuratel (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing nifuratel Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing diiodohydroxyquinoline Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only diiodohydroxyquinoline in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only diiodohydroxyquinoline (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only diiodohydroxyquinoline and hydrocortisone (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely diiodohydroxyquinoline 10 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing diiodohydroxyquinoline and hydrocortisone in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only diiodohydroxyquinoline and hydrocortisone in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely diiodohydroxyquinoline 650 milligram/1 each conventional release oral tablet Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely diiodohydroxyquinoline 210 milligram/1 each conventional release oral tablet Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing diiodohydroxyquinoline and hydrocortisone Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing diiodohydroxyquinoline in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clorquinaldol Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clorquinaldol and hydrocortisone in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clorquinaldol (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only clorquinaldol and hydrocortisone (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous cream Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clorquinaldol and hydrocortisone Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing clorquinaldol and hydrocortisone in cutaneous dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing oxyquinoline (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing acetic acid and oxyquinoline in vaginal dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only acetic acid and oxyquinoline in vaginal dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing acetic acid and oxyquinoline (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only acetic acid and oxyquinoline (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing indium (111-In) oxine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing glacial acetic acid and oxyquinoline (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only oxyquinoline (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only glacial acetic acid and oxyquinoline (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing ornidazole Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only ornidazole (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Propamidine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely propamidine isethionate 1 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing propamidine in ocular dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only propamidine in ocular dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely propamidine isethionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing propamidine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely propamidine isethionate 1 milligram/1 milliliter conventional release solution for eye drops (clinical drug) Plays role False Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing salinomycin Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only salinomycin (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing pafuramidine Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only pafuramidine (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only pafuramidine in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pafuramidine maleate 100 milligram/1 each conventional release oral tablet Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing pafuramidine in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing trimetrexate Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only trimetrexate (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing imidocarb Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only imidocarb (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing ipronidazole Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only ipronidazole (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely propamidine isethionate 1 milligram/1 milliliter conventional release eye drops (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nifurtimox 30 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nifurtimox 120 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely eflornithine (as eflornithine hydrochloride) 115 milligram/1 gram conventional release cutaneous cream (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely secnidazole 1 gram/1 each conventional release oral tablet (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ofloxacin 200 milligram and ornidazole 500 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only ofloxacin and ornidazole (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only ofloxacin and ornidazole in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing ofloxacin and ornidazole in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing ofloxacin and ornidazole (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing fexinidazole (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing fexinidazole in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only fexinidazole in oral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only fexinidazole (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fexinidazole 600 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely eflornithine hydrochloride 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benznidazole 50 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely suramin sodium 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely melarsoprol 36 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely meglumine antimoniate 300 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing meglumine antimoniate Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only meglumine antimoniate (medicinal product) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing meglumine antimoniate in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Product containing only meglumine antimoniate in parenteral dose form (medicinal product form) Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Acetarsol 500mg suppositories Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Miltefosine 50mg capsules Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Pentamidine 300mg/5ml nebuliser liquid Plays role False Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Zinc paste, Calamine and Clioquinol bandage BP 7.5cm x 6m Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Acetarsol 360mg suppositories Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Acetarsol 1g suppositories Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Miltefosine 10mg capsules Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Eflornithine 11.5% cream Plays role False Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Acetarsol 250mg suppositories Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Atovaquone 750mg/5ml oral suspension sugar free Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Nifurtimox 120mg tablets Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Benznidazole 50mg tablets Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Benznidazole 100mg tablets Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Sodium stibogluconate 10g/100ml solution for injection vials Plays role False Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Propamidine 0.1% eye drops Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Sodium stibogluconate 10g/100ml solution for injection vials Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Pentamidine 300mg/5ml nebuliser liquid Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Eflornithine 11.5% cream Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier
Secnidazole 2g granules sachets Plays role True Antiprotozoal therapeutic role Inferred relationship Existential restriction modifier

Start Page 2 of 3

This concept is not in any reference sets

Back to Start